PHARMACOKINETICS OF NAPROXEN IN SUBJECTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION

被引：52

作者：

ANTTILA, M ^{[1
]}

HAATAJA, M ^{[1
]}

KASANEN, A ^{[1
]}

机构：

[1] UNIV TURKU,DEPT MED,SF-20500 TURKU 50,FINLAND

来源：

关键词：

D O I：

10.1007/BF00563009

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：263 / 268

页数：6

共 23 条

[11] REIDENBERG M M, 1976, Clinical Pharmacokinetics, V1, P121, DOI 10.2165/00003088-197601020-00003
[12] BILIARY-EXCRETION OF DRUGS IN MAN
ROLLINS, DE
KLAASSEN, CD
[J]. CLINICAL PHARMACOKINETICS, 1979, 4 (05) : 368 - 379
[13] RUNKEL R, 1978, CLIN PHARMACOL THER, V24, P706
[14] RUNKEL R, 1973, Scandinavian Journal of Rheumatology Supplement, V2, P29
[15] RUNKEL R, 1974, CLIN PHARMACOL THER, V15, P261
[16] RUNKEL R, 1976, CLIN PHARMACOL THER, V20, P269
[17] RUNKEL RA, 1972, CHEM PHARM BULL, V20, P1457
[18] NAPROXEN METABOLISM IN MAN
SEGRE, EJ
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 15 (04) : 316 - 323
[19] STEIN G, 1977, INT J CLIN PHARM BI, V15, P470
[20] URINARY METABOLIC PROFILES FOR CHOOSING TEST ANIMALS FOR CHRONIC TOXICITY STUDIES - APPLICATION TO NAPROXEN
THOMPSON, GF
COLLINS, JM
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (06) : 937 - 941